Category: Cancer

Eric Lefkofsky’s Company Reached A Financial Milestone

Tempus, a company co-founded by Eric Lefkofsky, was granted a recent round of finances recently. In March of this year, Tempus gained $80 million more in funding. They received $70 million just six months before this last round of funding.

What is Tempus

Tempus is a company established in 2015 and is located in Chicago. It is a data-driven company used to fight against cancer. Tempus began upon the frustration of many in the healthcare system discarding tons of valuable data which could’ve helped against the detrimental effects of cancer. Even the co-founder, Lefkoksky, heartbrokenly experienced the traumatizing effects as one of his loved ones suffered from cancer.

With Lefkoksky’s passion and drive, he and his co-founder worked very hard to fight the good fight. They are making amazing strides towards the fight against cancer as they already have gained around $210 million in funding in just a little over two years of their existence. With their funding, they have hired tons of employees, amounting around 30 additional personnel each month. They currently have 400 employees, and they are planning on continuing to hire more employees especially in the tech and data science fields.

Tempus has also partnered with about half of the US healthcare centers. Additionally, they are teaming up with many independent oncologists and a non-profit health information platform called CancerLinQ which is an American Society of Clinical Oncology’s subsidiary.

Who is Eric Lefkofsky

Lefkofsky is an American businessman and serial entrepreneur. In addition to being a co-founder of Tempus, he is the Chief Executive Officer of this company. He was born and raised in a suburb outside of Detroit, Michigan. In 1991, Lefkofsky graduated from the University of Michigan with honors. He also earned his Juris Doctorate degree from the University of Michigan Law School in 1993.

To Read More Click Here

Eric Lefkofsky Uses His Creative Mind To Benefit Us All

Never before has there been so much collected data brought together from around the world on cancer, which is being done by a technological company known as Tempus. This company, started by Eric Lefkofsky, is going a long way towards improving the potential medical advancements coming in the near future thanks to the accumulation of genomic data.

Despite what most people think, the industry for healthcare around the world is typically lagging behind in terms of technology, using many outdated methods and systems still today. Through a personal experience with cancer, Eric got an up-close look at just how outdated these systems in healthcare really are, which inspired him to found Tempus. It is his desire to help advance the healthcare industry through technology for the future.

So far, there haven’t been many effective methods for using collected data from patients and treatments, so it has mostly just sat around collecting dust or getting lost in archives. Through Tempus, Eric Lefkofsky is delivering a new way for information to be used by medical professionals, which will hopefully aid in much more than just cancer research and treatments. Molecular and genomic data from around the world is collected from cancer patients as well as notes left by doctors. Tempus’ advanced algorithms allow it to not only analyze data but structures it in a way that allows it to be used effectively

Apart from being the co-founder of Tempus as well as the standing CEO, Eric Lefkofsky has also founded several other successful companies, amassing him quite a large fortune with which he uses to help the world around him each day. Eric has started up his own foundation to help support student education, and he regularly gets involved with charities. Eric has many board member positions at various companies today, which has given him a huge amount of experience in the business. Eric also regularly speaks at events and publishes his own articles to give insight into what it means to be successful in such a competitive field. All of which he does while continuing to innovate and create new ideas.

To know more visit @:

Chronic Diseases Could Increase Cancer Risk, According To Top Doc, Dr. David Samadi

Internationally recognized urologist, Dr. David Samadi says chronic diseases such as diabetes or cardiovascular problems could be responsible for over a fifth of new cancer cases and over a third of cancer deaths. The celebrity doctor, and Chairman of Urology at Lenox Hill Hospital pointed this out in his January broadcast of Sunday Housecall.

So chronic diseases could have the same weight as five known risk factors for cancer (smoking, sedentary lifestyle, insufficient consumption of fruit and vegetables, consumption of alcohol, obesity). From 1996 to 2007, researchers at the University of Texas in Houston, Department of Epidemiology, performed a study on 405,878 individuals, who were asked to complete a questionnaire on their medical history, lifestyles, and demographic information. According to the results of this study, the presence of some chronic diseases, like heart disease and diabetes, could also be added to these factors.

The study found that the increase in chronic disease led to an increased risk of developing tumors. In particular those who suffered from a greater number of chronic diseases had a double risk of developing cancer.

One of the most important aspects of medical care is communication. Here are some of Dr. Samadi’s tips you should embrace:

1. Know your family history. Having a family history of cancer among first-degree relatives not only increases the risk of developing a similar tumor, but also develops another type of cancer in other parts of the body. This should be communicated with your doctor.

2. Make doctor visits and have early screenings. Many people bypass doctor visits, especially when they don’t “feel” sick, but regular physicals are important. Dr. Samadi points out how examinations can lead to early diagnosis of diseases, prevention, and/or the discovery of tumors.

3. More control of lifestyle choices. Recent studies reveal that about 30% of cancer cases are related to our poor eating habits. An advocate of healthy nutrition, Dr. David Samadi points out how crucial it is to develop good lifestyle choices like paying more attention to our diets, and getting more exercise. Obesity, in general, is a risk factor for numerous cancers including colon and breast cancer, and It’s been shown that moderate physical activity reduces the risk of cancer.

Dr. David Samadi is the Chairman of Urology at Lenox Hill Hospital, and previously was Director at Columbia Presbyterian Hospital. He’s been a featured expert correspondent on Fox News, World Health News, and a host of radio programs including 1010 AM, and WNYM 970 AM. Dr. Samadi also hosts his own television show, Sunday Housecall.

He is is an international clinical expert on urologic diseases, developed the highly regarded SMART surgical technique for prostate cancer, and he’s been voted New York Metro Area Top Doctor, America’s Top Doctor, and received the Community Partner Award from the American Cancer Society.

Read More:

Eric Lefkofsky And The Fascinating Contribution Of His Tempus Labs In Battles Against Cancer

In general, entrepreneurship is such a risky game, and requires a lot of grit and courage. Those who win end up getting all of the cake, but those who fail will get more than nothing, because of the possibility of accumulated debt. Fortunately for people like Eric Lefkofksy and his company Tempus Labs, he’s able to withstand such challenges and still emerge thriving, relevant and profitable.

The Chicago Power

What probably made Tempus Labs one of the successful companies today is because it’s based in Chicago, a state where it’s conducive to start any type of business. Being one of the most influential companies in Chicago also means that Tempus Labs already has the roots to be outstanding and for people to trust more its products. This success might also be because the services offered in Tempus Labs are some of the most relevant and in-demand services today that many people will pay money for, which include cancer testing, sequencing of patients’ tumors and liquid biopsy of cell-free DNA. All of these programs are remarkably in-demand and almost necessary for people, and it’s such a clever move for Mr. Eric to capitalize on this.

Mr. Lefkosky is the co-founder of Tempus Labs, and his direct involvement in the company’s operations makes him more hands-on in its results and directives. For this reason, he makes sure that the testing he offers are just about right in its price points, giving more people access to necessary but otherwise expensive tests.

About Eric Lefkofsky

Eric is mainly known to be head officer and co-founder of Tempus Labs, a tech and health tests company that operates mainly to help battle cancer. The disruptive technologies today have a lot of potentials to help people undergoing cancer treatments or have loved ones who do, and Eric is mainly leveraging all these technologies to make sure that people can get the right methods, tools, data, and assistance they need.

Mr. Lefkofsky is also famous for being the adjunct professor at the University of Chicago, and the book about Accelerated Disruption that he authored remains to be a well referenced resource in modern health tech.

To Learn More Click Here

Eric Lefkofsky, Tempus Labs And The Use Of Big Data Analytics

The work of the Chicago based Tempus labs is poised to revolutionize cancer care through its big data analytics technology. Co-founded by entrepreneur Eric Lefkofsky, Tempus Labs works with several of the National Cancer Institute’s comprehensive cancer center throughout the U.S. and is among the nation’s leading health tech start-ups.

Tempus does cancer testing, performs liquid biopsies on cell-free DNA, sequencing of tumor and germline DNA in patients, sequencing of patient and tumor RNA, uses drugs to test tumor cells organoid cultures and immune system characterization. Tempus technology also handles machine learning of information from pathology reports, medical imaging as well as electronic medical records.

The company is included on the list of the 10 most impactful technologies compiled each year by Dr. Eric Topol. The list also includes a groundbreaking new deep-learning algorithm used to diagnose skin cancer, the KardiBand watch which diagnoses atrial fibrillation, gene editing and therapy biotechnologies and two amazing new sensors for monitoring blood glucose levels and directly dosing insulin.

Other innovations on the list include rapid pathogen sequencing technology which enables public health agencies to respond faster to disease outbreaks, CAR T immunotherapy for treating cancer patients, AI technology which offers faster, less expensive and more accurate eye disease diagnoses, the blood pressure watch, as well as the two drugs, tisagenlecleucel-T for use treating children and young patients suffering with acute lymphoblastic leukemia and Axicabtageneciloleucel for treating the aggressive form of B-cell non-Hodgkin lymphoma.

In addition to co-founding Tempus Labs, University of Michigan Law School graduate Eric Lefkofsky co-founded numerous other companies including Groupon. Lefkofsky lives in Chicago and is on the board of World Business Chicago, the Art Institute of Chicago, Chicago’s Lurie Children’s Hospital, Steppenwolf Theatre Company and The Museum of Science and Industry. Eric Lefkofsky wrote the book ‘Accelerated Disruption: Understanding the True Speed of Innovation’. He’s currently a University of Chicago adjunct professor at its Booth School of Business.

Eric Lefkofsky created the Lefkofsky Family Foundation. The organization has helped provide education, medical care, food, clothing, shelter and more for children and adults in need around the globe.

Read More:

Cancer Treatment Centers Of America Has New Employment Opportunities

Cancer Treatment Centers of America was founded recently, and its primary mission is to assist people who are living with cancer. The organization understands how dealing with cancer can be difficult for all the people involved. First of all, the patient needs counseling so that they can accept the situation and forge ahead with treatment. The families of the patients must be well prepared so that they can offer the support needed to cancer patient. Cancer Treatment Centers of America has covered all these areas in cancer and it is looking for ways to make sure that they are all covered.

Cancer Treatment Centers deal with cancer in several ways. First of all, the patients are diagnosed and taken through several processes so that they can accept what is happening to them due to the disease. The institution has a team of professionals who have all the skills needed to handle the process. These cancer specialists have been in the department for a long time, and they have all the knowledge needed. Before the organization hires its professionals, it has to make sure that they are the best. The professionals to work must have expertise before they can start to work in the successful cancer center.

Working with the Cancer Treatment Centers of American has so many benefits to all people. These professionals are given very good compensation at the end of the month so that they can be motivated to work hard in all the company sections. There are several other employee benefits such as transport, uniform and medical covers that the patients have to enjoy. These individuals must be dedicated to their work before they can be hired. Just recently, the cancer center announced that it was going to hire several professionals to assist in running medical facility. According to the medical company website, the individuals who are interested must send their applications to the emails provided so that they can be scheduled for an interview. The company has several positions needed, and all interested parties are encouraged to apply.

Apart from having experienced professionals to work in the company, the Cancer Treatment Centers of America prides itself for having some of the best facilities that can deal with all forms of cancer. This equipment plays an essential role in treatment of cancer. When the cancer is in advanced stages, the doctors in the facility will use chemotherapy, surgery and radiotherapy to make sure that the cancer is completely cured in the body.

To Read More Click Here

Eric Lefkofsky, Entrepreneurship and Philanthropy

Healthcare costs are increasing in the United States. Americans paid $933 billion more on healthcare in 2013 than they did merely 17 years before that in 1996. They can blame the cost increases on care fees that are higher than ever before. They can blame the increases on medical care that’s markedly more in-depth as well.

The population is expanding. Members of the population are getting older, too. These are other elements that contributed to the significant spike in spending. Numerous components are behind the serious change. Diabetes is one of them. This medical condition was associated with a substantial boost in spending on an annual basis. Pharmaceutical costs are also a big culprit.

Eric Paul Lefkofsky is a prominent individual who established Tempus, a renowned technology firm. Tempus is in the process of constructing the biggest clinical and molecular data network on the planet. It’s in the process of constructing an in-depth operating system that aims to streamline data access as well. Eric Lefkofsky has been on this planet since September of 1969. This esteemed entrepreneur functions as Tempus’ diligent Chief Executive Officer. He’s married to a woman who is called Elizabeth.

Lefkofsky has had a long and fulfilling career so far. He started out by handling carpet sales while a young student at the University of Michigan located in Ann Arbor, Michigan. He completed law school. Once he was through with law school, he asked family members for a loan. That’s precisely when he made the decision to purchase a Madison, Wisconsin based clothing brand. The brand was called Brandon Apparel. He purchased it alongside a pal he made in college. This was Brad Keywell.

Lefkofsky is an individual who has a commitment to entrepreneurship that’s matchless in intensity. He’s also a person who has a strong penchant for philanthropy work of all kinds. He set up a charitable trust in 2006. He did this with his wife. They named the trust “The Lefkofsky Foundation.” The aim in establishing this foundation was to help educational, science and charitable causes and groups from all different corners of the globe.

Read More :

Eric Lefkofsky; Bringing Big Data To The Health Sector

Until recently, oncologists had to comb through mountains of raw data of cancer patients to draw any meaningful information, but now Tempus has come to change that. Lack of standardized data has been one of the biggest impediments to effective cancer treatments. Most of the genomic and therapeutic information on people who are battling with various forms of cancer exists in the form of doctors’ notes. This reality lives doctors with very little information to act upon whenever they are prescribing treatment to their patients.

Entrepreneur Eric Lefskofsky has partnered with other players in the field of medicine to champion the next frontier in cancer treatment which is data-driven precision medicine. Through a joint venture called Tempus, the seasoned businessman is expected to revolutionize healthcare as far autoimmune diseases such as cancer are concerned and read full article.

It never dawned on Eric Lefkofsky that he could find his calling in the field of medicine. Eric had always been an investor in the area of technology and had developed several disruptive brands in this sector. In 2015, Eric Lefkofsky changed his course in business and decided to venture into medical research when someone close to him needed cancer treatment. It was at this moment of horror and pain that Eric made a life-changing discovery. Eric noticed that oncologists were working with limited data. Most of the information that existed was in forms which they couldn’t draw any meaningful analyses from it.

Eric decided to co-found a company that could speed up research in the medical field of oncology. Eric wanted to put effective therapies in the hands of cancer patients as soon as he could. Through Tempus, Eric’s dream is beginning to take shape one step after the other. Already, the company has begun analyzing medical records from over 1,000 breast cancer patients with the aim of drawing analytics that can help scientists come up with data-driven precision medicine and what Eric knows.

When a doctor is handling various cancer patients, they can compare the patient’s clinical and genomic data against that of other patients who are living with the same type of cancer. With various cases of cancer under one pool, doctors can be able to know what works and what doesn’t.

Apart from making a lot of progress in the field of entrepreneurship, Eric Lefkofsky is also a seasoned humanitarian. He is involved with initiatives that aim at making the world a better place for everyone and Eric’s lacrosse camp.

Impressionable Facts about Clay Siegall

Seattle Genetics is ranked among the most prestigious biotech companies in the United States and aims at further developing its operations is in the coming years. The firm has been playing a significant role of packaging and conducting studies on the various antibodies as well as their roles. Seattle Genetics has highly invested in doing researches concerning the human antibodies with the aim of discovering the most effective bone in attacking and thoroughly destroying cancer cells. The company has a great team of employees who are highly committed to delivering the best, and this has profoundly contributed to the high growth of the firm over the past years.

The firm has great strategies that enable it to stand out among many other companies in the market, and its unique antibody that delivers payloads of toxins to cancer cells has allowed the firm gain more prestige. Many individuals in Seattle hope that the company will keep growing in the coming years to become a prolific pharmaceutical company that they have been highly looking toward for a long time. Besides, they hope that the company will retain its current location in Seattle and that it will not reconsider relocating to another place regardless of its success. The people in Seattle are highly hopeful on the provision of better services for the firm and are willing to give their best concerning the research on the cancer antibody.

In addition to that, the company has over nine hundred employees and hopes to employ more in the coming years. It is also proud of its immense amount of net worth which has proved it to be one of the most prolific firms in the United States. Besides, Seattle Genetics is highly ambitious towards evolving from a biotech company into a massive pharmaceutical enterprise in the coming years. Its high reliance on research and marketing will see it hire more employees in the coming year.

Clay Siegal is one of the significant contributors to the success of the firm and is profoundly ambitious towards growing the company to a bigger and successful one. Clay is not willing to sell his form to other bigger pharmaceutical firms as he believes that its one major way of encouraging failure.

In addition to that, Clay has a lot of experience in the pharmaceutical field, and since appointment in the firm, he has shared his amendable skills with his team of employees which has, in turn, enhanced their performance. Besides, Clay has helped the company enter into partnerships with various pharmaceutical firms majoring in oncology which has helped it acquire ideas for more development.